Insomnia (eBook, PDF)
Diagnosis and Treatment
Redaktion: Sateia, Michael J.; Buysse, Daniel
62,95 €
62,95 €
inkl. MwSt.
Sofort per Download lieferbar
31 °P sammeln
62,95 €
Als Download kaufen
62,95 €
inkl. MwSt.
Sofort per Download lieferbar
31 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
62,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
31 °P sammeln
Insomnia (eBook, PDF)
Diagnosis and Treatment
Redaktion: Sateia, Michael J.; Buysse, Daniel
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung

Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.

Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
The first source on insomnia treatment since the advancement of newer drug options and cognitive behavioral therapies, Insomnia: Diagnosis and Treatment presents a comprehensive reference on the complications, evaluation, and treatment of insomnia. Ideal for sleep medicine specialists, psychiatrists, and neurologists, this text uses a multi-discipl
- Geräte: PC
- mit Kopierschutz
- eBook Hilfe
Andere Kunden interessierten sich auch für
- Restless Legs Syndrome (eBook, PDF)62,95 €
- Handbook of Sleep Disorders (eBook, PDF)62,95 €
- Treatment of Pediatric Neurologic Disorders (eBook, PDF)62,95 €
- Handbook of Parkinson's Disease (eBook, PDF)210,95 €
- Sleep Disorders and Neurologic Diseases (eBook, PDF)210,95 €
- Sleep Disorders (eBook, PDF)210,95 €
- Clinician's Guide to Sleep Disorders (eBook, PDF)165,95 €
-
-
-
The first source on insomnia treatment since the advancement of newer drug options and cognitive behavioral therapies, Insomnia: Diagnosis and Treatment presents a comprehensive reference on the complications, evaluation, and treatment of insomnia. Ideal for sleep medicine specialists, psychiatrists, and neurologists, this text uses a multi-discipl
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis eBooks
- Seitenzahl: 496
- Erscheinungstermin: 19. April 2016
- Englisch
- ISBN-13: 9781420080803
- Artikelnr.: 56962848
- Verlag: Taylor & Francis eBooks
- Seitenzahl: 496
- Erscheinungstermin: 19. April 2016
- Englisch
- ISBN-13: 9781420080803
- Artikelnr.: 56962848
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Michael J. Sateia, Daniel J. Buysse
Section I. Fundamentals of Insomnia. Introduction. History. Definitions.
Significance. Epidemiology. Consequences. Subjective and objective daytime
consequences. Socio-economic impact. Insomnia as a risk factor in disease.
Models. Psychological - cognitive/ behavioral models. Biological models.
Sleep EEG in insomnia. Neuro-endocrine/immune /autonomic /metabolic
function. Brain imaging. II. Clinical Assessment of Insomnia. Sleep
history. Evaluation instruments and methodology. Classification and
diagnosis overview. Primary insomnias. Secondary insomnias. Insomnia in
psychiatric disorders. Insomnia in chronic pain. Insomnia in medical and
neurological disorders. Insomnia in circadian rhythm disorders. Shift work
/ jet lag / DSP/ASP/Free-running - blindness. Insomnia in other sleep
disorders. Movement disorders. Breathing disorders. Substance-induced
insomnia. Insomnia In the elderly. Childhood insomnia. III. Treatment of
Insomnia. Overview of treatment considerations. Psychological and
behavioral therapies. Preface. Role of healthy sleep practices. Scheduling
/ role of exercise / caffeine/ alcohol. Specific behavioral treatment
modalities. Stimulus control. Sleep restriction. Cognitive therapy.
Short-term and group treatment approaches. Multimodal CBT. Specific
populations. Secondary insomnia. Elderly. Pharmacological treatment.
Pharmacology of the GABAA complex. BzRAs in the management of insomnia.
Indications/efficacy and outcome. Safety / adverse effects / tolerance /
withdrawal and rebound. Sedating antidepressants, neuroleptics, and other
prescription medications. Melatonin in sleep-wake regulation. Melatonin as
a hypnotic agent. Development of melatonin receptor agonists. Other
pharmacotherapies. Over-the-counter products. Nutritional supplements
/herbals. Emerging pharmacotherapies. Clinical trials in insomnia. Practice
Models. Treatment setting / staffing. Managing comorbid populations.
Combining and sequencing treatment modal
Significance. Epidemiology. Consequences. Subjective and objective daytime
consequences. Socio-economic impact. Insomnia as a risk factor in disease.
Models. Psychological - cognitive/ behavioral models. Biological models.
Sleep EEG in insomnia. Neuro-endocrine/immune /autonomic /metabolic
function. Brain imaging. II. Clinical Assessment of Insomnia. Sleep
history. Evaluation instruments and methodology. Classification and
diagnosis overview. Primary insomnias. Secondary insomnias. Insomnia in
psychiatric disorders. Insomnia in chronic pain. Insomnia in medical and
neurological disorders. Insomnia in circadian rhythm disorders. Shift work
/ jet lag / DSP/ASP/Free-running - blindness. Insomnia in other sleep
disorders. Movement disorders. Breathing disorders. Substance-induced
insomnia. Insomnia In the elderly. Childhood insomnia. III. Treatment of
Insomnia. Overview of treatment considerations. Psychological and
behavioral therapies. Preface. Role of healthy sleep practices. Scheduling
/ role of exercise / caffeine/ alcohol. Specific behavioral treatment
modalities. Stimulus control. Sleep restriction. Cognitive therapy.
Short-term and group treatment approaches. Multimodal CBT. Specific
populations. Secondary insomnia. Elderly. Pharmacological treatment.
Pharmacology of the GABAA complex. BzRAs in the management of insomnia.
Indications/efficacy and outcome. Safety / adverse effects / tolerance /
withdrawal and rebound. Sedating antidepressants, neuroleptics, and other
prescription medications. Melatonin in sleep-wake regulation. Melatonin as
a hypnotic agent. Development of melatonin receptor agonists. Other
pharmacotherapies. Over-the-counter products. Nutritional supplements
/herbals. Emerging pharmacotherapies. Clinical trials in insomnia. Practice
Models. Treatment setting / staffing. Managing comorbid populations.
Combining and sequencing treatment modal
Section I. Fundamentals of Insomnia. Introduction. History. Definitions.
Significance. Epidemiology. Consequences. Subjective and objective daytime
consequences. Socio-economic impact. Insomnia as a risk factor in disease.
Models. Psychological - cognitive/ behavioral models. Biological models.
Sleep EEG in insomnia. Neuro-endocrine/immune /autonomic /metabolic
function. Brain imaging. II. Clinical Assessment of Insomnia. Sleep
history. Evaluation instruments and methodology. Classification and
diagnosis overview. Primary insomnias. Secondary insomnias. Insomnia in
psychiatric disorders. Insomnia in chronic pain. Insomnia in medical and
neurological disorders. Insomnia in circadian rhythm disorders. Shift work
/ jet lag / DSP/ASP/Free-running - blindness. Insomnia in other sleep
disorders. Movement disorders. Breathing disorders. Substance-induced
insomnia. Insomnia In the elderly. Childhood insomnia. III. Treatment of
Insomnia. Overview of treatment considerations. Psychological and
behavioral therapies. Preface. Role of healthy sleep practices. Scheduling
/ role of exercise / caffeine/ alcohol. Specific behavioral treatment
modalities. Stimulus control. Sleep restriction. Cognitive therapy.
Short-term and group treatment approaches. Multimodal CBT. Specific
populations. Secondary insomnia. Elderly. Pharmacological treatment.
Pharmacology of the GABAA complex. BzRAs in the management of insomnia.
Indications/efficacy and outcome. Safety / adverse effects / tolerance /
withdrawal and rebound. Sedating antidepressants, neuroleptics, and other
prescription medications. Melatonin in sleep-wake regulation. Melatonin as
a hypnotic agent. Development of melatonin receptor agonists. Other
pharmacotherapies. Over-the-counter products. Nutritional supplements
/herbals. Emerging pharmacotherapies. Clinical trials in insomnia. Practice
Models. Treatment setting / staffing. Managing comorbid populations.
Combining and sequencing treatment modal
Significance. Epidemiology. Consequences. Subjective and objective daytime
consequences. Socio-economic impact. Insomnia as a risk factor in disease.
Models. Psychological - cognitive/ behavioral models. Biological models.
Sleep EEG in insomnia. Neuro-endocrine/immune /autonomic /metabolic
function. Brain imaging. II. Clinical Assessment of Insomnia. Sleep
history. Evaluation instruments and methodology. Classification and
diagnosis overview. Primary insomnias. Secondary insomnias. Insomnia in
psychiatric disorders. Insomnia in chronic pain. Insomnia in medical and
neurological disorders. Insomnia in circadian rhythm disorders. Shift work
/ jet lag / DSP/ASP/Free-running - blindness. Insomnia in other sleep
disorders. Movement disorders. Breathing disorders. Substance-induced
insomnia. Insomnia In the elderly. Childhood insomnia. III. Treatment of
Insomnia. Overview of treatment considerations. Psychological and
behavioral therapies. Preface. Role of healthy sleep practices. Scheduling
/ role of exercise / caffeine/ alcohol. Specific behavioral treatment
modalities. Stimulus control. Sleep restriction. Cognitive therapy.
Short-term and group treatment approaches. Multimodal CBT. Specific
populations. Secondary insomnia. Elderly. Pharmacological treatment.
Pharmacology of the GABAA complex. BzRAs in the management of insomnia.
Indications/efficacy and outcome. Safety / adverse effects / tolerance /
withdrawal and rebound. Sedating antidepressants, neuroleptics, and other
prescription medications. Melatonin in sleep-wake regulation. Melatonin as
a hypnotic agent. Development of melatonin receptor agonists. Other
pharmacotherapies. Over-the-counter products. Nutritional supplements
/herbals. Emerging pharmacotherapies. Clinical trials in insomnia. Practice
Models. Treatment setting / staffing. Managing comorbid populations.
Combining and sequencing treatment modal